Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
97
Frequently Asked Questions
What is Market Cap of Theravance Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Theravance Biopharma Inc market cap is $720.17M.
What is the 52-week high for Theravance Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Theravance Biopharma Inc 52 week high is $14.55 as of September 16, 2025.
What is the 52-week low for Theravance Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Theravance Biopharma Inc 52 week low is $7.88 as of September 16, 2025.
What is Theravance Biopharma Inc stock price today?
Theravance Biopharma Inc stock price today is $14.40.
What was Theravance Biopharma Inc stock price yesterday?
Theravance Biopharma Inc stock price yesterday was $14.30.
What is the PE ratio of Theravance Biopharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Theravance Biopharma Inc’s P/E ratio is 61.14.
What is the Price-to-Book ratio of Theravance Biopharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Theravance Biopharma Inc P/B ratio is 3.2029.
What is the 50-day moving average of Theravance Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Theravance Biopharma Inc 50-day moving average is $12.34.
How many employess does Theravance Biopharma Inc has?